This article has been updated to reflect the increased size of a study by Inova.

NEW YORK (GenomeWeb News) − The Inova Translational Medicine Institute has teamed up with Personalis for the analysis and clinical interpretation of whole-genome sequencing data from patients with undiagnosed syndromes, the partners said today.

Under the collaboration, ITMI, a non-profit research institute that is part of the Inova Health System, will perform whole-genome sequencing on patients with suspected genetic disease who have not been able to obtain a molecular diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.